A double blind, randomized placebo-controlled cross-over study on the cardiovascular effects of Salvia miltiorrhiza extract (Danshen) in patients with hypertension and hyperlipidemia
- Conditions
- elevated levels of lipids in the bloodhyperlipidemia1001331710057166
- Registration Number
- NL-OMON35218
- Lead Sponsor
- niversitair Medisch Centrum Sint Radboud
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
* Age: 40-70 (50% men / 50% women)
* Women:
- postmenopausal, or
- use of contraceptive pill
* Hyperlipidemia
- elevated level of triglycerides: > 1.7 mmol/L
- elevated level of LDL-cholesterol: > 3.5 mmol/L
- reduced level of HDL-cholesterol: < 1.03 mmol/L
* Hypertension:
- systolic pressure > 90 mm Hg
- diastolic pressure > 140 mm Hg
* Signed informed consent
* Smoking
* Alcohol or drug abuse
* History of cardiovascular disease (myocard infarct, angina pectoris, CVA, CI)
* Diabetes mellitus
* Pregnancy
* Concomitant (chronic) use of:
- ACE-inhibitors
- Statins
- Anticoagulant drugs
- > 1 antihypertensive drug
- High-dose antihypertensive medication (above defined daily dose)
- (Antioxidant) vitamin supplements
* Clinically significant liver disease (3 times the upper normal limit of ALAT,ASAT,AF, *GT or LDH)
* Clinically significant anemia (male Hb < 6,9 mmol/L, female < 6,25 mmol/L)
* Abnormal creatinine clearance (adjusted for age of subject)
* Participation to any drug-investigation during the previous 90 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Outcome parameters will be assessed in the 4th week of each treatment period.<br /><br>To study the effect of Danshen on hyperlipidemia, in particular<br /><br>LDL-cholesterol, but also HDL-cholesterol, total cholesterol, total<br /><br>triglycerides, apolipoprotein B plasma levels and LDL oxidation will be<br /><br>measured.</p><br>
- Secondary Outcome Measures
Name Time Method